BioAge Labs (BIOA) Other Accumulated Expenses (2023 - 2026)

BioAge Labs has disclosed Other Accumulated Expenses across 4 years of filings, most recently posting $714000.0 for Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $714000.0, up 27.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $714000.0 (up 27.96% YoY), and the FY2025 annual result was $525000.0, up 25.9% from the prior year.
• Other Accumulated Expenses came in at $714000.0 for Q1 2026 at BioAge Labs, up from $525000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.7 million in Q3 2024 to a low of $417000.0 in Q4 2024.
• The 4-year median for Other Accumulated Expenses is $802000.0 (2025), against an average of $892500.0.
• Across the five-year window, Other Accumulated Expenses plunged 69.98% in 2024 and advanced 27.96% in 2026, its largest moves.
• BioAge Labs' Other Accumulated Expenses stood at $1.4 million in 2023, then slumped by 69.98% to $417000.0 in 2024, then advanced by 25.9% to $525000.0 in 2025, then surged by 36.0% to $714000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $714000.0 (Q1 2026), $525000.0 (Q4 2025), and $890000.0 (Q3 2025), per Business Quant data.